ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK, said on Monday it has expanded its licensing deal with the Medicines Patent Pool to allow generic production of its long-acting ...

Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of ...

Joint venture between GlaxoSmithKline and Pfizer in HIV illustrates opportunities to develop combination pills to challenge current market leaders.

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing numbers into power.

Combination drug therapy articles from across Nature Portfolio A combination therapy is a therapeutic intervention in which more than one therapy is administered to the patient.

Clinical Experience of Combination Treatment Due, in part, to the logical nature of the approach, combination therapy is already widely used in clinical practice. Although compounds with a ...

In July 2020, Monjuvi in combination with lenalidomide received FDA approval for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise ...